Literature DB >> 2651759

Frequency of development of early cortical scarring in acute primary pyelonephritis.

A Meyrier1, M C Condamin, M Fernet, A Labigne-Roussel, P Simon, P Callard, M Rainfray, M Soilleux, A Groc.   

Abstract

Fifty-five cases of primary (that is, without urinary tract abnormalities), acute pyelonephritis (PN) were studied by computed tomodensitometry (CT). There were 48 women and 7 men. All were febrile and 16 had positive blood cultures. In 7 cases, (4 diabetics and 3 malnourished alcoholics) PN was painless, diagnosis was delayed and lesions were severe. Two diabetics underwent emergency nephrectomy for sepsis. Conventional radiological techniques (IVP and ultrasonography) were poorly informative. In contrast, initial CT abnormalities were visible in 44 patients. They consisted of triangular or round hypodense images, diffuse hypodensity in a grossly swollen kidney, and/or abscesses. Hypodense images were presumably due to acute focal ischemia. Renal histology was available in five patients. It showed acute interstitial nephritis with leukocyte infiltrates, edema and hemorrhagic streaks. Pyelonephritis was due to E. coli in 48 cases (87.5%). In 27 cases E. coli isolates were studied by genotypic assays which detect the three most frequent (pap, afa and sfa) of the four operons known to encode adhesin. In all cases, at least one of these genotypic markers of uropathogenicity was found. In 27 cases, repeat CT was done shortly after treatment. It showed healing in only 12. Early cortical scar formation was visible in 2. Final evaluation in 27 cases with adequate follow-up showed that (in addition to the 2 patients who had been nephrectomized), in only 17 of 27 (63%) had the kidneys recovered a normal appearance. In two cases one kidney had undergone atrophy; renal biopsy showed subacute-chronic interstitial nephritis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2651759     DOI: 10.1038/ki.1989.41

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Vesicoureteral Reflux in Childhood: Preventing urinary tract infections.

Authors:  W L Robson; A K Leung; W C Hyndman
Journal:  Can Fam Physician       Date:  1992-09       Impact factor: 3.275

2.  Ultrasonographic findings in acute renal infections.

Authors:  R Djerassi; R Krasteva; B Bogov; H Neshev; A Kundurdjiev
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Development of kidney scars after acute uncomplicated pyelonephritis: relationship with clinical, laboratory and imaging data at diagnosis.

Authors:  G B Piccoli; L Colla; M Burdese; C Marcuccio; E Mezza; J Maass; G Picciotto; A Sargiotto; L Besso; A Magnano; V Veglio; G Piccoli
Journal:  World J Urol       Date:  2006-01-21       Impact factor: 4.226

4.  Approach to urinary tract infections.

Authors:  M S Najar; C L Saldanha; K A Banday
Journal:  Indian J Nephrol       Date:  2009-10

Review 5.  Diagnosis and drug treatment of acute pyelonephritis.

Authors:  A Meyrier; J Guibert
Journal:  Drugs       Date:  1992-09       Impact factor: 9.546

6.  Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood--a 27-year follow-up.

Authors:  S H Jacobson; O Eklöf; L E Lins; I Wikstad; J Winberg
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

7.  Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction.

Authors:  C Le Bouguenec; M Archambaud; A Labigne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

8.  The clinical and imaging presentation of acute "non complicated" pyelonephritis: a new profile for an ancient disease.

Authors:  Giorgina Barbara Piccoli; Valentina Consiglio; Maria Chiara Deagostini; Melania Serra; Marilisa Biolcati; Francesca Ragni; Alberto Biglino; Agostino De Pascale; Mauro Felice Frascisco; Andrea Veltri; Francesco Porpiglia
Journal:  BMC Nephrol       Date:  2011-12-15       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.